Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease.
Monika JürgensonTamara ZharkovskajaAveli NoortootsMargarita MorozovaAllan BeniashviliMax ZapolskiAlexander ZharkovskyPublished in: The Journal of pharmacy and pharmacology (2019)
Our data suggest considerable potential for the use of memantine with melatonin in patients with AD.